β2-adrenergic agonists suppress rat autoimmune myocarditis: Potential role of β2-adrenergic stimulants as new therapeutic agents for myocarditis

Circulation

Volumn 114, Issue 9, 2006, Pages 936-944

  Nishii, Mototsugu ^a   Inomata, Takayuki ^a   Niwano, Hiroe ^a   Takehana, Hitoshi ^a   Takeuchi, Ichiro ^a   Nakano, Hironari ^a   Shinagawa, Hisahito ^a   Naruke, Takashi ^a   Koitabashi, Toshimi ^a   Nakahata, Jun Ichi ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Immune system; Myocarditis; Receptors, adrenergic, beta

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC MYOSIN; FORMOTEROL; GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; METOPROLOL; SALBUTAMOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ETHANOLAMINE DERIVATIVE; PRIMER DNA; PROPRANOLOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEMODYNAMICS; HISTOPATHOLOGY; LYMPH NODE CELL; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LEWIS RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENERGIC BETA-AGONISTS; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; DNA PRIMERS; ETHANOLAMINES; FEMALE; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-10; MYOCARDITIS; PROPRANOLOL; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33748366988     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.607903     Document Type: Article

References (35)

1. Nishii M, Inomata T, Takehana H, Takeuchi I, Nakano H, Koitabashi T, Nakahata J, Aoyama N, Izumi T. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol. 2004;44:1292-1297.
2. Hühl U, Noutsias M, Seeberg B, Schultheiss HP. Immunohistochemical evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart. 1996;75:295-300.
3. Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P, Liew CC. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation. 1990;82:8-16.
4. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res. 1994;75:278-284.
5. Nakamura H, Yamamura T, Umemoto S, Fukuta S, Shioi T, Matsumori A, Sasayama S, Matsuzaki M. Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice. Circulation. 1996;94:3348-3354.
6. Rose NR, Hill SL. The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol. 1996;80:S92-S99.
7. Hubes SA, Lodge PA. Coxsackievirus B3 myocarditis in BALB/c mice: evidence for autoimmunity to myocyte antigens. Am J Pathol. 1984;116:21-29.
8. Lauer B, Padberg K, Schultheiss HP, Strauer BE. Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy. Z Kardiol. 1995;84:301-310.
9. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol. 1983;52:1072-1078.
10. Okura Y, Takeda K, Honda S, Hanawa H, Watanabe H, Kodama M, Izumi T, Aizawa Y, Seki S, Abo T. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res. 1998;82:1035-1042.
11. Okura Y, Yamamoto T, Goto S, Inomata T, Hirono S, Hanawa H, Feng L, Wilson CB, Kihara I, Izumi T, Shibata A, Aizawa Y, Seki S, Abo T. Characterization of cytokine and iNOS mRNA expression in situ during the course of experimental autoimmune myocarditis in rats. J Mol Cell Cardiol. 1997;29:491-502.
12. Borger P, Hoekstra Y, Esselink MT, Postma DS, Zaagsma J, Vellenga E, Kauffman HF. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am J Respir Cell Mol Biol. 1998;19:400-407.
13. Panina-Bordignon P, Mazzeo D, Lucia PD, D'Ambrosio D, Lang R, Fabbri L, Self C, Sinigaglia F. Beta2-agonists prevent Th1 development by selective inhibition of interleukin-12. J Clin Invest. 1997;100:1513-1519.
14. Malfait AM, Malik AS, Marinova-Mutafchieva L, Butler DM, Maini RN, Feldmann M. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J Immunol. 1999;162:6278-6283.
15. Inomata T, Hanawa H, Miyanishi T, Yajima E, Nakayama S, Maita T, Kodama M, Izumi T, Shibata A, Abo T. Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circ Res. 1995;76:726-733.
16. van der Molen T, Sears MR, de Graaff CS, Postma DS, Meyboomde Jong B, for the Canadian and Dutch Formoterol Investigators. Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Eur Respir J. 1998;12:30-34.
17. Sponer G, Bartsch W, Strein K, Muller-Beckmann B, Bohm E. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypertensive properties. J Cardiovasc Pharmacol. 1987;9:317-327.
18. Takehana H, Inomata T, Niwano H, Nishii M, Matsuda C, Kohno K, Machida Y, Izumi T. Immunomodulatory effect of pentoxifyline in suppressing experimental autoimmune myocarditis. Jpn Circ J. 2002;66:499-504.
19. Hanawa H, Abe S, Hayashi M, Yoshida T, Yoshida K, Shiono T, Fuse K, Ito M, Tachikawa H, Kashimura T, Okura Y, Kato K, Kodama M, Maruyama S, Yamamoto T, Aizawa Y. Time course of gene expression in rat experimental autoimmune myocarditis. Clin Sci. 2002;103:623-632.
20. Wegmann KW, Zhao W, Griffin AC, Hickey WF. Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. J Immunol. 1994;153:892-900.
21. Nishio R, Matsumori A, Shioi T, Wang W, Yamada T, Ono K, Sasayama S. Denopamine, a beta1-adrenergic agonist, prolongs survival in a murine model of congestive heart failure induced by viral myocarditis: suppression of tumor necrosis factor-alpha production in the heart. J Am Coll Cardiol. 1998;32:808-815.
22. Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property. Am J Physiol. 2004;286:83-90.
23. Nishio R, Shioi T, Sasayama S, Matsumori A. Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol. 2003;41:340-345.
24. Kodama M, Matsumoto Y, Fujiwara M. In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation. 1992;85:1918-1926.
25. Futamatsu H, Suzuki J, Kosuge H, Yokoseki O, Kamada M, Ito H, Inobe M, Isobe M, Uede T. Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. Cardiovasc Res. 2003;59:95-104.
26. Watanabe K, Nakazawa M, Fuse K, Hanawa H, Kodama M, Aizawa Y, Ohnuki T, Gejyo F, Maruyama H, Miyazaki J. Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation. 2001;104:1098-1100.
27. Futamatsu H, Suzuki J, Mizuno S, Koga N, Adachi S, Kosuge H, Maejima Y, Hirao K, Nakamura T, Isobe M. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res. 2005;96:823-830.
28. Kodama M, Zhang S, Hanawa H, Shibata A. Immunohistochemical characterization of infiltrating mononuclear cells in the rat heart with experimental autoimmune giant cell myocarditis. Clin Exp Immunol. 1992;90:330-335.
29. Kavelaars A, van de Pol M, Zijlstra J, Heijnen CJ. Beta2-adrenergic activation enhances interleukin-8 production by human monocytes. J Neuroimmunol. 1997;77:211-216.
30. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin-10 production during human endotoxemia. J Clin Invest. 1996;97:713-719.
31. Wang JF, Meissner A, Malek S, Chen Y, Ke Q, Zhang J, Chu V, Hampton TG, Crumpacker CS, Abelmann WH, Amende I, Morgan JP. Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. Am J Physiol. 2005;289:1577-1583.
32. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000;101:558-569.
33. Communal C, Singh K, Sawyer DB, Colucci WS. Opposing effects of beta1- and beta2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation. 1999;100:2210-2212.
34. Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci WS, Bristow MR, Port DJ. Myocardial-directed overexpression of the human beta1-adrenergic receptor in transgenic mice. J Mol Cell Cardiol. 2000;32:817-830.
35. Rockman HA, Hamilton RA, Jones LR, Milano CA, Mao L, Lefkowitz RJ. Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein. J Clin Invest. 1996;97:1618-1623.